Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [21] Marine bioactive compounds and health promoting perspectives; innovation pathways for drug discovery
    Suleria, Hafiz Ansar Rasul
    Gobe, Glenda
    Masci, Paul
    Osborne, Simone A.
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2016, 50 : 44 - 55
  • [22] Network approaches to drug discovery
    Chandra, Nagasuma
    Padiadpu, Jyothi
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (01) : 7 - 20
  • [23] Drug discovery: In silico dry data can bypass biological wet data?
    Tognolini, Massimiliano
    Lodola, Alessio
    Giorgio, Carmine
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (03) : 340 - 344
  • [24] Targeting cell signaling pathways for drug discovery: An old lock needs a new key
    Aggarwal, Bharat B.
    Sethi, Gautam
    Balaclandayuthapani, Veera
    Krishnan, Sunil
    Shishodia, Shishir
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (03) : 580 - 592
  • [25] Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications
    Namasivayam, Aishwarya Alex
    Ferreiro Morales, Alejandro
    Fajardo Lacave, Angela Maria
    Tallam, Aravind
    Simovic, Borislav
    Garrido Alfaro, David
    Bobbili, Dheeraj Reddy
    Martin, Florian
    Androsova, Ganna
    Shvydchenko, Irina
    Park, Jennifer
    Val Calvo, Jorge
    Hoeng, Julia
    Peitsch, Manuel C.
    Velez Racero, Manuel Gonzalez
    Biryukov, Maria
    Talikka, Marja
    Berraquero Perez, Modesto
    Rohatgi, Neha
    Diaz-Diaz, Noberto
    Mandarapu, Rajesh
    Amian Ruiz, Ruben
    Davidyan, Sergey
    Narayanasamy, Shaman
    Boue, Stephanie
    Guryanova, Svetlana
    Arbas, Susana Martinez
    Menon, Swapna
    Xiang, Yang
    GENE REGULATION AND SYSTEMS BIOLOGY, 2016, 10 : 51 - 66
  • [26] Accurate calculations in drug discovery research: the biological roles of magnesium and calcium ions
    Richards, W. Graham
    MOLECULAR PHYSICS, 2009, 107 (8-12) : 819 - 822
  • [27] Plants of Indian origin in drug discovery
    Mukherjee, Pulok K.
    Rai, Sujay
    Kumar, V.
    Mukherjee, Kakali
    Hylands, P. J.
    Hider, R. C.
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (05) : 633 - 657
  • [28] Towards reproducible computational drug discovery
    Schaduangrat, Nalini
    Lampa, Samuel
    Simeon, Saw
    Gleeson, Matthew Paul
    Spjuth, Ola
    Nantasenamat, Chanin
    JOURNAL OF CHEMINFORMATICS, 2020, 12 (01)
  • [29] Systems approaches to polypharmacology and drug discovery
    Boran, Aislyn D. W.
    Iyengar, Ravi
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (03) : 297 - 309
  • [30] Robust Target Identification for Drug Discovery
    Jacobsen, Elling W.
    Nordling, Torbjorn E. M.
    IFAC PAPERSONLINE, 2016, 49 (07): : 815 - 820